Pharmaceutical
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach €1.8 billion by 2025, according to a new report.
